These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 21684569)

  • 61. The effect of human fetal liver-derived mesenchymal stem cells on CD34+ hematopoietic stem cell repopulation in NOD/Shi-scid/IL-2Rã(null) mice.
    Yang HM; Cho MR; Sung JH; Yang SJ; Nam MH; Roh CR; Kim JM; Shin M; Song SH; Kwon CH; Joh JW; Kim SJ
    Transplant Proc; 2011 Jun; 43(5):2004-8. PubMed ID: 21693316
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intrahepatic transplantation of CD34+ cord blood stem cells into newborn and adult NOD/SCID mice induce differential organ engraftment.
    Wulf-Goldenberg A; Keil M; Fichtner I; Eckert K
    Tissue Cell; 2012 Apr; 44(2):80-6. PubMed ID: 22197619
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intrahepatic transplantation of cord blood CD34+ cells into newborn NOD/SCID-IL2Rγ(null) mice allows efficient multi-organ and multi-lineage hematopoietic engraftment without accessory cells.
    Navarro-Montero O; Romero-Moya D; Montes R; Ramos-Mejía V; Bueno C; Real PJ; Menendez P
    Clin Immunol; 2012 Nov; 145(2):89-91. PubMed ID: 22964517
    [No Abstract]   [Full Text] [Related]  

  • 64. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene.
    King M; Pearson T; Shultz LD; Leif J; Bottino R; Trucco M; Atkinson MA; Wasserfall C; Herold KC; Woodland RT; Schmidt MR; Woda BA; Thompson MJ; Rossini AA; Greiner DL
    Clin Immunol; 2008 Mar; 126(3):303-14. PubMed ID: 18096436
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Exogenous oestrogen inhibits genital transmission of cell-associated HIV-1 in DMPA-treated humanized mice.
    Quispe Calla NE; Vicetti Miguel RD; Glick ME; Kwiek JJ; Gabriel JM; Cherpes TL
    J Int AIDS Soc; 2018 Jan; 21(1):. PubMed ID: 29334191
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells.
    Wang X; Zhang W; Tripodi J; Lu M; Xu M; Najfeld V; Li Y; Hoffman R
    Blood; 2010 Dec; 116(26):5972-82. PubMed ID: 20858855
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [The observation of engraftment of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model by intra-bone marrow injection].
    Gao JT; Lu SH; Li YH; Yang Z; Xu J; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jun; 29(6):361-5. PubMed ID: 19031735
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A humanized mouse model to study human immune response in xenotransplantation.
    Ji M; Jin X; Phillips P; Yi S
    Hepatobiliary Pancreat Dis Int; 2012 Oct; 11(5):494-8. PubMed ID: 23060394
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development of a humanized mouse model to study the role of macrophages in allograft injury.
    Kirkiles-Smith NC; Harding MJ; Shepherd BR; Fader SA; Yi T; Wang Y; McNiff JM; Snyder EL; Lorber MI; Tellides G; Pober JS
    Transplantation; 2009 Jan; 87(2):189-97. PubMed ID: 19155972
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Hematopoietic reconstitution of fresh and cultured cord blood CD34+ cells in NOD/SCID mice].
    Yang S; Cai HB; Jin HL; Tan WS
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Oct; 24(10):947-9. PubMed ID: 18845075
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In utero transplantation of human fetal haemopoietic cells in NOD/SCID mice.
    Turner CW; Archer DR; Wong J; Yeager AM; Fleming WH
    Br J Haematol; 1998 Nov; 103(2):326-34. PubMed ID: 9827901
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Similar myeloid recovery despite superior overall engraftment in NOD/SCID mice after transplantation of human CD34(+) cells from umbilical cord blood as compared to adult sources.
    Noort WA; Wilpshaar J; Hertogh CD; Rad M; Lurvink EG; van Luxemburg-Heijs SA; Zwinderman K; Verwey RA; Willemze R; Falkenburg JH
    Bone Marrow Transplant; 2001 Jul; 28(2):163-71. PubMed ID: 11509934
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice.
    Schiedlmeier B; Kühlcke K; Eckert HG; Baum C; Zeller WJ; Fruehauf S
    Blood; 2000 Feb; 95(4):1237-48. PubMed ID: 10666196
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pathology of macrophage activation syndrome in humanized NSGS mice.
    Tarrant JC; Binder ZA; Bugatti M; Vermi W; van den Oord J; Ranieri B; Assenmacher CA; Hoepp N; O'Rourke DM; Shan X; Danet-Desnoyers G; Radaelli E
    Res Vet Sci; 2021 Jan; 134():137-146. PubMed ID: 33383491
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease.
    Roesler J; Brenner S; Bukovsky AA; Whiting-Theobald N; Dull T; Kelly M; Civin CI; Malech HL
    Blood; 2002 Dec; 100(13):4381-90. PubMed ID: 12393624
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Development of mature and functional human myeloid subsets in hematopoietic stem cell-engrafted NOD/SCID/IL2rγKO mice.
    Tanaka S; Saito Y; Kunisawa J; Kurashima Y; Wake T; Suzuki N; Shultz LD; Kiyono H; Ishikawa F
    J Immunol; 2012 Jun; 188(12):6145-55. PubMed ID: 22611244
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice.
    Lepus CM; Gibson TF; Gerber SA; Kawikova I; Szczepanik M; Hossain J; Ablamunits V; Kirkiles-Smith N; Herold KC; Donis RO; Bothwell AL; Pober JS; Harding MJ
    Hum Immunol; 2009 Oct; 70(10):790-802. PubMed ID: 19524633
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Conditions that enable human hematopoietic stem cell engraftment in all NOD-SCID mice.
    Rice AM; Wood JA; Milross CG; Collins CJ; McCarthy NF; Vowels MR
    Transplantation; 2000 Mar; 69(5):927-35. PubMed ID: 10755552
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nonirradiated NOD,B6.SCID Il2rγ-/- Kit(W41/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells.
    McIntosh BE; Brown ME; Duffin BM; Maufort JP; Vereide DT; Slukvin II; Thomson JA
    Stem Cell Reports; 2015 Feb; 4(2):171-80. PubMed ID: 25601207
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
    Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
    Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.